Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Checkmate Pharmaceuticals Q3 EPS $(0.69) Up From $(0.84) YoY

Checkmate Pharmaceuticals (NASDAQ:CMPI) reported quarterly losses of $(0.69) per share. This is a 17.86 percent increase over losses of $(0.84) per share from the same period last year.
byBenzinga Newsdesk
November 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Checkmate Pharmaceuticals (NASDAQ:CMPI) reported quarterly losses of $(0.69) per share. This is a 17.86 percent increase over losses of $(0.84) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Zuora’s Earnings: A Preview

By Benzinga Insights
May 24, 11:25 AM
Zuora (NYSE:ZUO) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Zuora will report an earnings per share (EPS) of $-0.01.

ZUO